Loxitane
This medication is formulated to target schizophrenia symptoms and is intended to alleviate cognitive and behavioural disturbances in patients.
- Category
- Mental Health
- Active ingredient
- Loxapine
- Supply
- Rx
- Route
- Oral use
- Form
- Tablet
- Strengths
- 10 · 25mg
Loxitane details
- Condition
- Schizophrenia
- Therapeutic class
- Typical Antipsychotic
- Pharmacological class
- Dibenzoxazepine
- Minor side effects
- sedation; dizziness; dry mouth
- Moderate side effects
- extrapyramidal symptoms; constipation; blurred vision
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- Teva
- Onset Time
- 1–2 hours
- Duration
- 12–24 hours
- Storage instructions
- Store at room temperature, protected from light and moisture.
- Drug interactions
- alcohol; central nervous system depressants; epinephrine
- Age restrictions
- Not indicated for children.
Contraindications
hypersensitivity to loxapine; severe central nervous system depression; history of closed-angle glaucoma; urinary retention; comatose states
Precautions and warnings
risk of tardive dyskinesia; monitor for signs of neuroleptic malignant syndrome; may impair ability to drive or operate machinery
Serious side effects
neuroleptic malignant syndrome, requires immediate medical attention; tardive dyskinesia, requires immediate medical attention
Patient summary
This medication is formulated to target schizophrenia symptoms and is intended to alleviate cognitive and behavioural disturbances in patients.
Mechanism of action
Loxapine is a typical antipsychotic that acts by blocking dopamine D2 receptors in the brain. By inhibiting these pathways, it modulates central nervous system activity, providing relief from the symptoms associated with psychotic disorders like schizophrenia.
Pregnancy and breastfeeding
Pregnancy: Use only if the potential benefit justifies the risk. Breastfeeding: Breastfeeding is not recommended during treatment.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Loxitane
Loxitane is an antipsychotic medication containing loxapine, used in the management of schizophrenia. Produced by Teva, it is supplied as an oral tablet in strengths of 10mg and 25mg. Patients often rely on these specific dosages to maintain their therapeutic routines across different care settings.
Loxitane availability in Asia
Loxitane is registered across 5 global markets, including Hong Kong and the UAE. Generic loxapine, often manufactured in India, offers a more affordable alternative to the original brand for patients requiring steady access. As with all antipsychotic treatments, this medication is best used under the direct care and supervision of a doctor.